Main Industry
Health Care
Main Product/Service
Medeon develops advanced medical devices for minimally‑invasive surgery across cardiovascular, orthopedic, urology, and neuro fields, and provides a full lifecycle platform — from design and preclinical/clinical validation to mass production and commercia
Founded Year
2012
Unified Business No.
54150856
Status
Active
Name of Representative
Yue Teh Jang
Number of Employees
20
Total Paid-in
Capital
922,448,930 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
OTC listing(2016)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Medeon Biodesign, Inc. is a Taipei‑based medtech company focused on bringing novel medical devices from concept to commercialization by partnering with physicians, entrepreneurs, and global industry players to address unmet clinical needs.
